Effect of remote ischemic preconditioning among donors and recipients following pediatric liver transplantation: A randomized clinical trial

Table 3 Comparisons of clinical outcomes in recipients

	DR-RIPC, n = 51	D-RIPC, n = 51	R-RIPC, n = 51	S-RIPC, n = 55	P value
Duration in ICU in h	115.2 (113.6, 126.2)	113.1a (91.0, 114.8)	114.6 (91.3, 116.1)	114.3 (92.5, 138.2)	0.041
Time of ventilation in h	17.7 (16.7, 18.7)	17.8 (16.9, 18.9)	17.6 (17.1, 19.0)	17.8 (16.5, 19.2)	0.941
EAD	6	11	5	8	0.350
PNF	0	0	1	2	0.343
AKI	0	0	0	0	/
Postoperative complications					0.870
≤ 3a	46	50	45	50
> 3a	5	1	6	5

^aP < 0.05, donors received remote ischemic preconditioning group vs Both donors and recipients received remote ischemic preconditioning group. Variables are shown as “median (25% quartile, 75% quartile)”. AKI: Acute kidney injury; D-RIPC: Donors received remote ischemic preconditioning; DR-RIPC: Both donors and recipients received remote ischemic preconditioning; EAD: Early allograft dysfunction; ICU: Intensive care unit; PNF: Primary nonfunction; R-RIPC: Recipients received remote ischemic preconditioning; S-RIPC: Remote ischemic preconditioning with no intervention.